Immunotherapy is set to revolutionise the treatment of cancer, according to ESMO President Professor Rolf A. Stahel. His comments come as the ESMO Symposium on Immuno-Oncology 2014 is about to
Eur. Chronic Disease Alliance manifesto just published: common sense on #chronicdiseases #ECDA
ESMOChannel: #IMPAKT15 a unique opportunity to facilitate advancement of a personalised approach to #breastcancer
We're accepting abstracts for #ELCC15 European #lungcancerconference 15-18 Apr 2015. Submit your abstract now!
Open access: webcasts and presentations from ESMO Preceptorship on #Immunotherapy of Cancer on #OncologyPRO
FDA approves Gardasil 9 for the prevention of certain diseases caused by 9 types of #HPV
New website section dedicated to research funding opportunities created to promote and improve clinical cancer research in Europe
It is approved in combination with paclitaxel, pegylated liposomal doxorubicin, or topotecan
Researchers identify mutations expressed within melanoma that predict effective responses to a groundbreaking immunotherapy
RT @GustaveRoussy: Pour tout savoir sur le robot Da Vinci Xi et la chirurgie robotique en #oncologie
New: Guide for Patients with Follicular Lymphoma is available in English, Dutch, French and Spanish
ESMOChannel: J. Haanen comments on the interesting results of research presented at ESMO Symposium on Immuno-Oncology (Geneva 21-22 Nov 2014) revealing that high-dose interleukin-2 can be effective in selected #metastatic
Applications for ESMO-ESO Course on #MedicalOncology for #MedicalStudents (16-21 July 2015 , Valencia) is now open!
ESMOChannel: S. Peters & G. Tortora present an overview of Signalling Pathways 2015 pmme #personalisedmedicine
New evidence that immune checkpoint inhibitors may work in glioblastoma and brain metastases was presented today by Dr Anna Sophie Berghoff at the ESMO Symposium on Immuno-Oncology 2014 in Geneva,
Live from ESMO webinar: tips & tricks before you start – Build your consortium early: the best partners will quickly be committed!
Webcasts from Immuno-Oncology 2014 are now online and can be accessed by all ESMO members and conference attendees
Comprehensive cervical cancer control and prevention approach for governments and healthcare providers
Early results of the USA Intergroup clinical study
New ESMO E-Learning module "Tumour Heterogeneity in Breast Cancer" by Leticia de Mattos-Arruda is now out. View the presentation and, if you are an ESMO member, take the CME test!
The phase II study results
ESMO President, R. Stahel announces his vision for the society. Focus on research: developing a better environment for clinical and translational research in Europe to find better treatments for cancer